Indoco Remedies Quarterly Results for Trading Insights
INDOCO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-9 Cr
QSept 2025
Indoco Remedies Quarterly Results Key Highlights
- Revenue of ₹473 Cr in Sept 2025 (+22.5% vs Mar 2025, +9.5% vs Sept 2024)
- Net Profit of ₹-9 Cr in Sept 2025 (+78.0% vs Mar 2025, +10.0% vs Sept 2024)
- EBITDA of ₹30 Cr in Sept 2025 (+700.0% vs Mar 2025)
- Operating Margin of 6.0% in Sept 2025 (+8.0pp vs Mar 2025)
- Earnings Per Share of ₹-1.00 in Sept 2025 (+77.7% vs Mar 2025)
Indoco Remedies Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 473 | 386 | 433 | 432 | 462 | 22.5% | 9.5% |
| Net Profit (₹ Cr) | -9 | -41 | -36 | -10 | 22 | - | - |
| EBITDA (₹ Cr) | 30 | -5 | 10 | 40 | 61 | - | - |
| EPS (₹) | -1.00 | -4.48 | -3.94 | -1.09 | 2.39 | - | - |
| Operating Margin (%) | 6.0% | -2.0% | 2.0% | 9.0% | 9.0% | - | - |
Indoco Remedies Share Price Trend Around Quarterly Results
Visualize Indoco Remedies's 1-year price movement across quarterly results — ideal for logging trades in Indoco Remedies share price
chart using Tickjournal. All values in ₹.
Related Pages for Indoco Remedies
Additional stock information and data for INDOCO
Revenue Trend (₹ Cr)
Sept 2024
432
Jun 2025
433
Mar 2025
386
Sept 2025
473
Net Profit Trend (₹ Cr)
Sept 2024
-10
Jun 2025
-36
Mar 2025
-41
Sept 2025
-9
Operating Margin Trend (%)
Sept 2024
9.0%
Jun 2025
2.0%
Mar 2025
-2.0%
Sept 2025
6.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Indoco Remedies quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores